Text Size
1063 studies found for:    Endometrial Cancer: Clinical Trials

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Endometrial Cancer: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Condition: Endometrial Cancer
Interventions: Procedure: Intensive/Low-Risk Treatment (IA G1; IA G2);   Procedure: Intensive/High-Risk Treatment (≥ IA G3);   Procedure: Minimalist/Low-Risk Treatment (IA G1; IA G2);   Procedure: Minimalist/High-Risk Treatment (≥ IA G3)
2 Active, not recruiting Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Sarcoma
Interventions: Other: communication analysis;   Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables
3 Active, not recruiting The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: BN83495;   Drug: Megestrol Acetate (MA)
4 Recruiting Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Interventions: Biological: E39 peptide vaccine;   Other: Clinical tracking for disease progression/recurrence
5 Completed Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: EC145
6 Recruiting Safety, PK of AKT and MEK Combination
Condition: Cancer
Interventions: Drug: GSK1120212;   Drug: GSK2141795
7 Active, not recruiting Risk Factors for Endometrial Cancer in Black Women
Condition: Endometrial Cancer
Interventions: Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: evaluation of cancer risk factors
8 Recruiting An Endometrial Cancer Chemoprevention Study of Metformin
Condition: Gynecology
Interventions: Drug: Metformin;   Other: Placebo;   Procedure: Endometrial Biopsy;   Behavioral: Lifestyle Intervention;   Behavioral: Questionnaires
9 Recruiting Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: lymphadenectomy;   Procedure: therapeutic conventional therapy;   Procedure: Positron Emission Tomography/ Computed Tomography;   Radiation: fludeoxyglucose F 18
10 Not yet recruiting A Study of XL184 (Cabozantinib) in Endometrial Cancer
Conditions: Metastatic;   Endometrial Cancer;   Endometrioid;   Serous;   Mix Histology;   Carcinosarcoma;   Clear Cell;   Adenosquamous
Intervention: Drug: XL-184
11 Recruiting A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Drug: PF-05212384
12 Completed Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery
Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
13 Completed A Study of Letrozole in the Treatment of Endometrial Cancer
Condition: Recurrent and Metastatic Endometrial Cancer
Intervention: Drug: Letrozole
14 Completed CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: temsirolimus
15 Terminated Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Conditions: Uterine Cancer;   Endometrial Cancer
Intervention: Procedure: P2X7 Assay
16 Not yet recruiting Study Comparing AEZS-108 to Doxorubicin as a Second Line Therapy of Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: AEZS-108 / zoptarelin doxorubicin;   Drug: doxorubicin
17 Completed Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: medroxyprogesterone
18 Unknown † Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Condition: Endometrial Cancer
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
19 Completed Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)
Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus;   Drug: medroxyprogesterone acetate tablets OR megestrol acetate;   Drug: chemotherapy
20 Recruiting Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: Radiation Therapy;   Drug: cisplatin;   Drug: carboplatin;   Drug: Paclitaxel
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years